Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MALAT1 is a highly conserved long non-coding RNA (lncRNA) with significant roles in cancer biology and gene regulation. It is implicated in several key cellular processes including gene expression, alternative splicing, and acts as an endogenous microRNA sponge. Elevated levels are associated with radio-/chemotherapy resistance and poor prognosis across multiple malignancies, making it a potential therapeutic target.
Antisense oligonucleotides targeting MALAT1 reduce tumor growth and metastasis in preclinical mouse models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1).